Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

15.9K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
15.9K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

29
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
29
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

18.7K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
18.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PRIMUS: a precision medicine platform reusing clinical trials and registry data to support treatment selection in multiple sclerosis.

JAMIA open·2026
Same author

High frequency of the HLA-G*01:05N null allele in Beninese populations and its potential impact on reduced soluble HLA-G expression.

Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases·2026
Same author

HLA Class II Protein Expression Regulation Is Strongly Linked to Cis-Acting SNPs.

HLA·2026
Same author

Genome-wide association study reveals two novel genetic loci associated with chronic lung allograft dysfunction.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

A bidirectional two-sample Mendelian randomization study of immune responses against Epstein-Barr virus nuclear antigen 1 and multiple sclerosis in individuals of European ancestry.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Genetic Determinants of Multiple Sclerosis Susceptibility in People From Diverse Ancestral Backgrounds.

Neurology·2026

Related Experiment Video

Updated: Feb 24, 2026

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
04:41

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration

Published on: January 9, 2020

19.5K

Imputing HLA-G high-resolution alleles and regulatory haplotypes from exomes and SNP array data.

Rafaela Miranda Barbosa1, Nayane Dos Santos Brito Silva2, Diogo Meyer3

  • 1Department of Biochemistry and Immunology, Division of Basic and Applied Immunology, Ribeirão Preto Medical School, University of São Paulo (USP), Ribeirão Preto, SP, Brazil.

Human Immunology
|February 22, 2026
PubMed
Summary

Researchers developed imputation models to predict Human Leukocyte Antigen-G (HLA-G) haplotypes from genomic data. This enables comprehensive HLA-G analysis using widely available datasets, advancing research in immune regulation and disease.

Keywords:
Disease-association studyHLA-GImputationPolymorphismsRegulatory haplotypes

More Related Videos

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.8K
Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

13.6K

Related Experiment Videos

Last Updated: Feb 24, 2026

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
04:41

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration

Published on: January 9, 2020

19.5K
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.8K
Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

13.6K

Area of Science:

  • Immunogenetics
  • Genomic Medicine

Background:

  • Human Leukocyte Antigen-G (HLA-G) is an immune checkpoint molecule with crucial roles in immune privilege and pathology.
  • HLA-G exhibits limited coding diversity but significant regulatory variation, influencing its expression.
  • Genetic variants in HLA-G are structured into haplotypes due to strong linkage disequilibrium.

Purpose of the Study:

  • To develop and validate imputation models for predicting complete HLA-G haplotypes, including regulatory regions.
  • To enable comprehensive HLA-G analysis from commonly available genomic data types like whole-exome sequencing and SNP arrays.
  • To facilitate the study of HLA-G's role in various biological contexts without requiring full-gene sequencing.

Main Methods:

  • Construction of multi-ethnic reference panels using data from 5,347 individuals across three cohorts.
  • Development of HIBAG-based imputation models to predict HLA-G 4-field alleles, promoter, and 3'UTR haplotypes.
  • Validation of models through cross-validation and independent datasets.

Main Results:

  • High accuracy imputation models for HLA-G alleles and haplotypes were developed.
  • Exome-based imputation achieved >99% accuracy for common alleles, with mean posterior probabilities >0.95.
  • SNP array-based imputation demonstrated robust performance with >95% accuracy.

Conclusions:

  • The developed imputation approach allows simultaneous prediction of coding and regulatory HLA-G sequences.
  • This method enhances the utility of existing genomic datasets for HLA-G research.
  • Facilitates investigation of HLA-G's involvement in immune regulation, transplantation, cancer, and pregnancy complications.